Retrospective cohort analysis shows similar survival outcomes for SPTCL patients treated at academic and community cancer centers, implying access variations do not affect prognosis.
Key Points
To assess the impact of treatment facility type, race/ethnicity, and socioeconomic factors on treatment and survival in subcutaneous panniculitis-like T-cell lymphoma.
Retrospective cohort study of SPTCL patients from the National Cancer Database between 2004 and 2022.
Comparison of patient demographics, treatment modalities, and survival outcomes between academic and community cancer programs.
Survival analysis using Kaplan-Meier curves and Cox proportional hazards model adjustments.
460 patients with SPTCL were included, with 229 treated at academic cancer programs and 93 at community cancer programs.
Median age at diagnosis was lower in academic programs (57 years) compared to community (60 years).
No significant differences in survival outcomes between facility types, with adjusted median overall survival of 16.67 years in ACPs and 17.86 years in CCPs.